A new study finds children and teens with obesity or diabetes who take GLP-1 weight-loss medications experience significant improvements in many cardiometabolic risk factors, but long-term safety questions remain.
Health News is provided as a service to San Andreas Pharmacy site users by HealthDay. San Andreas Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.